MediPharm Labs Corp.
(TSX-V: LABS) Executive Team
MediPharm is built on the foundation of a strong executive team, with professionals from complementary industries that include global pharmaceuticals, healthcare, energy, and biotechnology manufacturing. Our company is a recognized leader in the Cannabis industry, and our science-based team delivers quality and innovation through research, discipline, and forward thinking.
CEO & Chairman of the Board
Before founding MediPharm Labs, Pat enjoyed a 15-year career in the pharmaceutical industry in top sales roles, successfully launching a wide range of medical products. He most recently worked at Jansen Pharmaceuticals (Johnson & Johnson) where he led the Hospital Division for Renal and Mental Health products. Pat’s foresight in creating a business that focuses on advanced cannabis concentrates bodes well for medical research, investors and consumers alike. Pat holds an Honors Bachelor of Science degree in biology from the University of Western Ontario.
President & Director
Keith Strachan co-founded MediPharm Labs in 2015, utilizing his consultancy expertise in Public Sector RFP and government contracts, compliance for government licensing and local planning, to break the mold and secure the first Health Canada Licence for cannabis oil production without first being a cultivator. A seasoned entrepreneur, Keith has applied his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce, while also strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.
Chief Operating Officer
David Mayers brings over 28 years of pharmaceutical leadership in large multinational firms and small privately held organizations, with extensive experience in corporate strategy and oversight, research and development ("R&D"), quality, lean sigma, production, supply chain, procurement, information technology, finance, product development, product launch, facility expansion, security and the management of controlled substances. Starting his career as a chemist for SmithKline Beecham (now GlaxoSmithKline), David progressed through roles of increasing responsibility for Taro Pharmaceutical Industries Ltd., Merck KGaA, Apotex Inc. and later Purdue Pharma (Canada). Most recently, David served as the Chief Operating Officer and member of the Board of Directors for Impopharma Inc., a pharmaceutical company specializing in the development and launch of pulmonary and nasal inhalation pharmaceutical products. In his role at Impopharma Inc., David led a turn-around of the company's R&D programs and facilitated its acquisition. David received his Hons. B.Sc. in Biological Science from the University of Guelph and an MBA from the Rotman School of Business, University of Toronto.
General Counsel and Head of Corporate Development & Corporate Secretary
Ahmed comes to MediPharm after having spent over a decade working in the Bay Street offices of the Business Law Group of one of the world's largest law firms and in the Corporate Law Group of a global leader in Canadian business law. His legal practice consisted of securities law, mergers & acquisitions, corporate finance and general corporate and commercial law. Ahmed has acted as external counsel for numerous cannabis companies and has been involved in a legal advisory role in the going public transactions of cannabis companies as well as companies in several other industries. He holds a Juris Doctor Law Degree from Osgoode Hall Law School and a Bachelor of Commerce Honours Degree with First Class Honours from the Queen's University School of Business.
Executive Vice President, Global Accounts
A Molecular Biologist by training, Kirk Binns was a founding shareholder of MediPharm Labs. A serial entrepreneur, Kirk has spent most of his career in the North American deregulated energy markets, leading market expansions, client acquisitions and managed up to 100 reports across multiple markets. Over the last 12 years, he established and ran a multinational energy sales organization generating 7-figures annually, while also contributing to MediPharm Labs’ start-up and operations. Kirk takes on the role of EVP, Global Accounts to help MediPharm Labs realize its vision as the trusted global leader in cannabinoid-based derivatives.
Chief Financial Officer & Director
Over the past 18 years, Chris has acted as Chief Financial Officer for several private and public companies operating in the resource, health sciences, and technology sectors. Chris is a member of the Chartered Accountants of Ontario and holds a Bachelor of Business Administration from the Schulich School of Business at York University.
Chief Marketing Officer
A 25-year marketing veteran, Sybil has brought premium consumer brands to life by developing innovative customer-focused marketing strategies. She launched Steam Whistle Pilsner in 2000 as a pioneering upstart and helped it grow to the largest craft beer brand in Canada. As CMO at Nuuvera Canada, Sybil was a senior contributor to this Canadian Cannabis start-up via strategic planning and brand development for medical and recreational brands. Sybil has been part of senior teams in two of Canada’s Best Managed Companies, and through CSR initiatives, she has brought numerous awards and public profile to her managed brands.
Vice President, Finance
Over his 12-year career, Jason has provided financial expertise to various public entities in capital market strategies, M&A advisory, valuation, financial forecasting and financial due diligence. Most recently, Jason held senior finance positions at Aurora Cannabis Inc., playing a key role in their merger with MedReleaf Corp. He previously worked in the strategy and corporate development group at Methanex Corporation, held roles at FTI Consulting Inc., and MNP LLP, in transaction advisory capacities, and held positions in the audit and assurance practice at PricewaterhouseCoopers LLP, Canada. Mr. Nalewany is a Canadian Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Victoria.
Vice President, Business Development
Prior to joining MediPharm Labs, Mike has spent over 10 years in professional services focused in Management Consulting, Enterprise Risk, and Transaction Advisory Services, working in the US and Canada. He has served as national lead supporting cannabis industry Licensed Producers and ancillary cannabis businesses. Mike has attained the Certified Public Accountant (CPA) designation and obtained his Masters of Accounting (MAcc) from USC. In addition, Michael is an alumnus of the Governor Generals Canadian Leadership Conference (GGCLC).
Vice President, Investor Relations & Communications
Laura Lepore brings more than 16 years of award-winning Investor Relations, Communications and Capital Markets experience across Financial, Industrial and Mining sectors. Laura was most recently AVP, Investor Relations at Home Capital Group Inc. and led IR through two significant transactions and a governance renewal. During her tenure with TD Bank Financial Group she held various roles in IR and Corporate Banking. Previously Laura was Director of IR for Newmarket Gold and Crocodile Gold. She earned her Bachelor of Arts, Economics from York University and is currently a Board Director for the Canadian Investor Relations Institute, Ontario Chapter.
Dr. Chris Talpas
Vice President, Quality and Scientific Affairs
Chris has 24 years of experience in the bio-pharmaceutical field, having been involved in all aspects of development from bench-top to commercial manufacture. After completing his BSc. and Doctorate degrees in Biochemistry, he joined Hemosol as a research scientist and then transitioned into the Process Development group where he worked on scaling up the manufacturing process to support clinical manufacturing of a haemoglobin-based blood substitute. Thereafter, he managed the clinical manufacturing plant. An expert in Chromatography, Dr. Talpas comes to MediPharm with a wealth of expertise in the qualification and validation of complex processes and equipment, as well as the development and maintenance of quality systems, having just served as the Director of Manufacturing Sciences at Therapure Biopharma.
Dr. Ina Dubinsky
Lead Scientist – Secondary Processing
Dr. Dubinsky recently held the position of Research and Development Scientist at ARA – Avanti Rx Analytics Inc. where she conducted analytical lab-testing and method development of tests for cannabis oil, extract, plant and intermediate products within Health Canada, Food and Drug Administration and Good Manufacturing Practices regulatory frameworks. Her experience includes research, development and performance of different extraction processes for cannabis and hemp, as well as isolation and purification of cannabinoids by vacuum distillation, vacuum filtration and Normal and RF column chromatography. Dr. Dubinsky is a Postdoctoral Fellow in Biochemistry from the University of Toronto, and she earned her PhD in Inorganic Chemistry from Tel Aviv University.
Director of Security
Paul has a 35-year career in policing and is dedicated to serving fellow citizens and advancing policing as a profession. He has successfully built bridges between community groups and the Ontario government and is currently the Executive Director of Ontario Police Technology Information Co-operative. Paul is the former president of the Ontario Association of Chiefs of Police.
Managing Director, MediPharm Labs Australia
Warren brings a wealth of senior leadership to MediPharm Labs Australia, having run both his own small businesses as well as achieved success in the Asia Pacific for a leading international digital marketing agency. Warren completed an Honours Bachelor Computer Science (programming) and was on the leading edge of web development and digital marketing, working first in Canada and the UK before building the Asia Pacific division of a large enterprise marketing agency, MarketOne. Over 8 years, Warren opened four offices, adding 200+ staff in Melbourne, Singapore, Bangalore and Tokyo. He boasts a 15-year history in sales and marketing, consulting to some of the biggest companies in the world.
Dr. Jake Golding
Director of Quality - Australia
Jake has nearly 20 years of experience in the bio-tech, medical device and pharmaceutical fields, in the development and commercialisation of a variety of products. After completing his BSc. and Doctorate degrees in Chemistry, he joined the Commonwealth Scientific and Industrial Research Organisation as a post-doctoral fellow. He then transitioned into private industry joining Southern Dental International in product development before moving to Boron Molecular taking up Operational and Quality Manager positions. With a wide range of experience in process and production chemistry, Dr. Golding comes to MediPharm Labs with a wealth of expertise in the registration, qualification and validation of processes, facilities and equipment, as well as the development and maintenance of quality systems. Jake most recently served as the Head of Quality at Medical Developments International.
Director of Global Regulatory and Scientific Affairs
Anuja has 8 years of experience in cannabis research, academia and work in the regulated cannabis industry in Canada. Most recently, Anuja worked as a Senior Quality/Regulatory Consultant at Cannabis Compliance Inc., global cannabis consulting firm. In that role, she provided quality and regulatory consulting services to over 50 clients, assisting with operational gap assessment and GPP/GMP audits, guiding close to one dozen clients with licence receipt from Health Canada, and navigating through the cannabis regulatory jurisdiction of multiple countries/US states. Previously Anuja worked for 2.5 years at Aphria Inc., one of Canada’s leading LPs in a senior role in the Quality Department. She has spoken at numerous scientific conferences and published in peer-reviewed scientific journals. Anuja holds a Master’s degree in Medical Sciences Program from McMaster University.
Director of Human Resources
Lorna has a 25-year career as a Human Resources executive working in both the UK and Canada, with a forward-thinking perspective. For the last nine years she headed up the Human Resources department at Steam Whistle Brewing, developing and implementing best practices to build high performing teams aligned to company objectives and values. Lorna is an approachable, collaborative leader with expertise in recruitment and on-boarding of new talent, and development of employees and managers through trusted mentoring and coaching. Lorna was part of the senior leadership team at Steam Whistle Brewing which won many awards, including 9-years recognition as one of Canada's Best Managed Companies. Lorna completed the Post Graduate Human Resource Management program from Ryerson University.
Director, Project Management Office
Saravan has worked in the Pharmaceutical Industry for over 12 years in roles focusing on Engineering and Technical Services. He has led projects which included new product launches in both Manufacturing and Commercial environments, and the design of a $30M High Containment Facility for the manufacturing of Soft Gel Capsules. Previously, he was a Project Manager in the Automotive Sector. Saravan is an authentic leader of successful teams by modelling a collaborative and hands on approach, providing opportunities for shared leadership, communicating effectively and motivating teams towards shared goals. Saravan obtained his bachelor’s degree in Electrical Engineering at the University of Waterloo, and recently completed his Executive MBA at the Rotman School of Management, University of Toronto.